Literature DB >> 16624543

The disposal of radioactive ferric floc.

N C Collier1, N B Milestone, J Hill, I H Godfrey.   

Abstract

An iron hydroxide floc is used as treatment for adsorbing low amounts of actinides during nuclear fuel re-processing. This waste is cemented only after pre-treatment with Ca(OH)(2). Characterisation of all simulant material has been undertaken using XRD, TGA and SEM/EDS. The floc is a moderately alkaline colloidal slurry containing approximately 15wt% solids, with the main particulate being an amorphous hydrated iron oxide. The main phase formed during pre-treatment appears to be an X-ray amorphous hydrated calcium-ferrate phase. Embedded within this are small amounts of crystalline Ca(OH)(2), calcite, Fe(6)(OH)(12)(CO(3)), Ca(6)Fe(2)(SO(4))(3)(OH)(12).26H(2)O and Ca(3)B(2)O(6), and can form depending on concentrations of Ca(OH)(2) and time. Apart from Ca(OH)(2) and calcite, none of the crystalline phases detected during pre-treatment are detected when the floc is encapsulated in an OPC/PFA composite cement hydrated for 90 days. The main crystalline phase detected in the hardened wasteform is a solid solution hydrogarnet, Ca(3)AlFe(SiO(4))(OH)(8), known as C(3)(A,F)SH(4) in cement chemistry nomenclature.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16624543     DOI: 10.1016/j.wasman.2006.01.031

Source DB:  PubMed          Journal:  Waste Manag        ISSN: 0956-053X            Impact factor:   7.145


  2 in total

1.  Removal of doxycycline hydrochloride from aqueous solution by rice husk ash using response surface methodology and disposability study.

Authors:  Gurleenjot Kaur; Neetu Singh; Anita Rajor; Raj Kumar Arya
Journal:  Environ Sci Pollut Res Int       Date:  2022-02-14       Impact factor: 4.223

2.  Incorporation of Uranium into Hematite during crystallization from ferrihydrite.

Authors:  Timothy A Marshall; Katherine Morris; Gareth T W Law; Francis R Livens; J Frederick W Mosselmans; Pieter Bots; Samuel Shaw
Journal:  Environ Sci Technol       Date:  2014-03-18       Impact factor: 9.028

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.